Roth Keeps Ligand (LGND) at 'Buy' Following New Captisol-Based Tech Launch

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/26/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. GOOGL
7. RNG
8. SPY
9. TMUS
10. UNP

Go back to Roth Keeps Ligand (LGND) at 'Buy' Following New Captisol-Based Tech Launch
LIGAND PHARMA (NASDAQ: LGND) Delayed: 300.53 -1.62 (0.54%)
Previous Close $302.15    52 Week High $139.79 
Open $302.72    52 Week Low $82.07 
Day High $307.81    P/E 698.91 
Day Low $297.18    EPS $0.43 
Volume 277,028